We next investigated the role of the specific activation of STAT3 Tyr705 in hypoxic ovarian cancer cells using a deletion mutant at Tyr705 (Phusion Site-Directed Mutagenesis method, Thermo Scientific). This evidence concerns the gene STAT3 and ovarian carcinoma.